EG24177A - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- EG24177A EG24177A EG132598A EG132598A EG24177A EG 24177 A EG24177 A EG 24177A EG 132598 A EG132598 A EG 132598A EG 132598 A EG132598 A EG 132598A EG 24177 A EG24177 A EG 24177A
- Authority
- EG
- Egypt
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/36—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9722817.5A GB9722817D0 (en) | 1997-10-29 | 1997-10-29 | Novel compounds |
GBGB9813689.8A GB9813689D0 (en) | 1998-06-25 | 1998-06-25 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
EG24177A true EG24177A (en) | 2008-09-28 |
Family
ID=26312507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG132598A EG24177A (en) | 1997-10-29 | 1998-10-29 | Novel compounds |
Country Status (36)
Country | Link |
---|---|
US (3) | USRE43390E1 (tr) |
EP (3) | EP1452534A1 (tr) |
JP (2) | JP4227729B2 (tr) |
KR (1) | KR100538721B1 (tr) |
CN (1) | CN1205211C (tr) |
AR (1) | AR015987A1 (tr) |
AT (2) | ATE525373T1 (tr) |
AU (1) | AU742167C (tr) |
BR (1) | BR9814747B1 (tr) |
CA (1) | CA2307551C (tr) |
CO (1) | CO5021129A1 (tr) |
CY (2) | CY2007028I1 (tr) |
CZ (1) | CZ298543B6 (tr) |
DE (2) | DE69826704T3 (tr) |
DK (2) | DK1028961T5 (tr) |
DZ (1) | DZ2634A1 (tr) |
EG (1) | EG24177A (tr) |
ES (2) | ES2371205T3 (tr) |
FR (1) | FR07C0057I2 (tr) |
HK (1) | HK1031376A1 (tr) |
HU (2) | HU229792B1 (tr) |
IL (2) | IL135811A0 (tr) |
LU (1) | LU91372I2 (tr) |
MY (1) | MY130665A (tr) |
NL (1) | NL300304I2 (tr) |
NO (3) | NO327392B1 (tr) |
NZ (1) | NZ504203A (tr) |
PE (1) | PE123299A1 (tr) |
PL (2) | PL197672B1 (tr) |
PT (2) | PT1028961E (tr) |
SI (2) | SI1930330T1 (tr) |
TR (1) | TR200001203T2 (tr) |
TW (1) | TWI232861B (tr) |
UY (1) | UY25225A1 (tr) |
WO (1) | WO1999021855A1 (tr) |
ZA (1) | ZA989767B (tr) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY25225A1 (es) * | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
WO2000027790A1 (en) * | 1998-11-11 | 2000-05-18 | Smithkline Beecham P.L.C. | Mutilin compounds |
GB9912657D0 (en) * | 1999-06-01 | 1999-07-28 | Smithkline Beecham Plc | Novel compounds |
GB9918037D0 (en) * | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
GB9919839D0 (en) * | 1999-08-20 | 1999-10-27 | Smithkline Beecham Plc | Novel compounds |
AU2001263827B2 (en) * | 2000-04-04 | 2004-06-17 | Smithkline Beecham Plc | 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
GB0017073D0 (en) * | 2000-07-11 | 2000-08-30 | Univ London | Microorganism |
GB0017031D0 (en) | 2000-07-11 | 2000-08-30 | Biochemie Gmbh | Antimicrobials |
PE20020676A1 (es) * | 2000-09-13 | 2002-08-27 | Biochemie Gmbh | Compuestos de mutilina como antibacterianos |
GB0024811D0 (en) * | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
GB0027705D0 (en) | 2000-11-11 | 2000-12-27 | S P A | Novel compounds |
FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
GB0207495D0 (en) * | 2002-03-28 | 2002-05-08 | Biochemie Gmbh | Organic compounds |
ES2295657T3 (es) * | 2002-07-24 | 2008-04-16 | Nabriva Therapeutics Forschungs Gmbh | Derivados de pleuromutilina como antimicrobianos. |
GB0218578D0 (en) * | 2002-08-09 | 2002-09-18 | Glaxo Group Ltd | Novel method |
GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
DE602004024417D1 (de) * | 2003-09-03 | 2010-01-14 | Glaxo Group Ltd | Neues verfahren zur herstellung von pleuromutilinderivaten |
EP1747219A4 (en) * | 2004-05-13 | 2010-05-26 | Glaxo Group Ltd | Antagonists of muscarinic acetylcholine receptor |
GB0504314D0 (en) * | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
EP1860943A4 (en) * | 2005-03-10 | 2008-06-18 | Smithkline Beecham Corp | NOVEL PROCEDURE |
EP1896404B1 (en) * | 2005-06-27 | 2014-09-17 | Nabriva Therapeutics AG | Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
GB0513058D0 (en) * | 2005-06-27 | 2005-08-03 | Sandoz Ag | Organic compounds |
WO2007037518A1 (ja) * | 2005-09-29 | 2007-04-05 | Dainippon Sumitomo Pharma Co., Ltd. | ムチリン誘導体及びそれを含有する医薬組成物 |
WO2007079173A2 (en) * | 2005-12-30 | 2007-07-12 | Emergent Biosolutions Inc. | Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents |
AU2008212171A1 (en) | 2007-02-09 | 2008-08-14 | Astellas Pharma Inc. | Aza-bridged-ring compound |
WO2008117796A1 (ja) * | 2007-03-28 | 2008-10-02 | Dainippon Sumitomo Pharma Co., Ltd. | 新規ムチリン誘導体 |
US8222407B2 (en) | 2007-05-24 | 2012-07-17 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
US20090076071A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched retapamulin |
US20090234125A1 (en) * | 2007-11-26 | 2009-09-17 | Eli Lancry | Amorphous retapamulin and processes for preparation thereof |
US20090149655A1 (en) * | 2007-12-05 | 2009-06-11 | Lilach Hedvati | Process for the preparation of Retapamulin and its intermediates |
US8278313B2 (en) | 2008-03-11 | 2012-10-02 | Abbott Laboratories | Macrocyclic spiro pyrimidine derivatives |
US8436005B2 (en) | 2008-04-03 | 2013-05-07 | Abbott Laboratories | Macrocyclic pyrimidine derivatives |
WO2010056855A1 (en) * | 2008-11-13 | 2010-05-20 | Teva Pharmaceutical Industries Ltd. | Preparation of retapamulin via its pleuromutilin-thiol precursor |
JP5422821B2 (ja) * | 2009-03-03 | 2014-02-19 | 独立行政法人放射線医学総合研究所 | コリンエステラーゼ活性測定用試薬 |
CN102510862A (zh) | 2009-07-14 | 2012-06-20 | 阿尔巴尼分子研究公司 | 5-ht3受体调节剂、其制备方法和用途 |
CN102344397B (zh) * | 2011-08-23 | 2013-09-04 | 浙江升华拜克生物股份有限公司 | 一种伐奈莫林盐酸盐的提纯方法 |
CN103626693B (zh) * | 2012-08-28 | 2016-09-14 | 中国科学院上海药物研究所 | 一类截短侧耳素衍生物、其药物组合物及其合成方法与用途 |
CN103709093B (zh) * | 2012-09-28 | 2016-06-08 | 山东亨利医药科技有限责任公司 | 含有并环的截短侧耳素类抗生素 |
US10258222B2 (en) | 2014-07-21 | 2019-04-16 | Endochoice, Inc. | Multi-focal, multi-camera endoscope systems |
CN109152932B (zh) * | 2016-03-02 | 2021-09-28 | 比尔及梅琳达盖茨基金会 | 含硼小分子 |
US10874679B2 (en) | 2016-03-02 | 2020-12-29 | Bill & Melinda Gates Foundation | Boron-containing small molecules |
CN113563368A (zh) | 2016-03-02 | 2021-10-29 | 比尔及梅琳达盖茨基金会 | 含硼小分子 |
CN106496085B (zh) * | 2016-09-21 | 2018-01-26 | 盐城市舜宝化工有限公司 | 合成盐酸沃尼妙林的中间体化合物以及盐酸沃尼妙林的制备方法 |
TWI762573B (zh) | 2017-02-10 | 2022-05-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素之純化 |
CN111574395B (zh) * | 2020-06-18 | 2021-07-02 | 华南农业大学 | 一种具有酰胺侧链的截短侧耳素衍生物及制备与应用 |
AT523646B1 (de) | 2020-07-21 | 2021-10-15 | Gerd Dr Ascher | Pharmazeutische Verbindungen, ihre Anwendung alleine oder in Kombination, zur Prophylaxe und lokalen Initial-Therapie bei bakteriellen und viralen Infektionen, insbesondere Coronaviren |
US11155514B1 (en) * | 2020-12-19 | 2021-10-26 | Shaanxi University Of Science And Technology | Pleuromulin acitretin ester with antibacterial activity and a method of preparing the same |
US11332430B1 (en) * | 2021-01-25 | 2022-05-17 | Xi'an Taikomed Pharmaceutical Technology Co., Ltd. | Pleuromulin lauric acid ester with antibacterial activity and a method of preparing the same |
CN112919463B (zh) * | 2021-04-09 | 2021-10-26 | 南京理工大学 | 一种利用泰妙菌素废盐制备的活性炭及其制备方法 |
CN113121355B (zh) * | 2021-04-13 | 2023-05-09 | 西安康诺化工有限公司 | 一种截短侧耳素大黄酸酯及其制备方法和应用 |
CN114736194A (zh) * | 2022-03-29 | 2022-07-12 | 中牧实业股份有限公司 | 一种具有抗病原微生物活性的含吡啶季铵盐侧链的截短侧耳素衍生物及其制备方法与应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4060542A (en) * | 1969-07-25 | 1977-11-29 | Biochemie Gesellschaft M.B.H. | 14-Desoxy-14 thiocyanato-acetoxy-mutilin |
CH575375A5 (tr) | 1972-05-25 | 1976-05-14 | Sandoz Ag | |
US4032530A (en) | 1971-10-05 | 1977-06-28 | Sandoz Ltd. | Certain pleuromutilins |
BE789629A (fr) * | 1971-10-05 | 1973-04-03 | Sandoz Sa | Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique |
US3919290A (en) | 1972-10-03 | 1975-11-11 | Sandoz Ltd | Substituted 14-desoxy-mutilins |
US4208326A (en) | 1971-10-05 | 1980-06-17 | Sandoz Ltd. | Pleuromutilin esters |
CH593912A5 (en) | 1972-07-07 | 1977-12-30 | Sandoz Ag | Pleuromutilin derivs. - prepd. by acylating derivs. contg. a (4)-hydroxyalkyl-(1)-piperazinyl gp. |
DE2404046C3 (de) | 1974-01-29 | 1984-07-26 | Henkel KGaA, 4000 Düsseldorf | Verwendung von Carboxyl- bzw. Carboxylat- und Hydroxylgruppen aufweisenden Polymeren als Hautfeuchthaltemittel |
US3987194A (en) | 1975-05-12 | 1976-10-19 | E. R. Squibb & Sons, Inc. | Use of pleuromutilin derivatives for the treatment of swine dysentery |
CH619450A5 (tr) | 1976-01-15 | 1980-09-30 | Sandoz Ag | |
US4130709A (en) | 1977-12-08 | 1978-12-19 | Eli Lilly And Company | Pleuromutilin glycoside derivatives |
GB2025930B (en) * | 1978-06-01 | 1983-02-09 | Sandoz Ltd | Process for the production of pleuromutilin derivatives |
DE2966635D1 (en) * | 1979-01-12 | 1984-03-08 | Sandoz Ag | New pleuromutilin derivatives, their production and pharmaceutical compositions containing them |
JPS5594359A (en) * | 1979-01-12 | 1980-07-17 | Sandoz Ag | Novel pleuromutilin derivatives*their manufacture and use |
FR2502951B1 (fr) | 1981-04-06 | 1985-12-06 | Sandoz Sa | Compositions pharmaceutiques topiques sous forme d'une micro-emulsion |
DE3405632A1 (de) * | 1984-02-17 | 1985-08-22 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung |
DE3560511D1 (en) * | 1984-02-17 | 1987-10-01 | Sandoz Ag | Pleuromutilin derivatives, process for their preparation and their use |
AT400674B (de) | 1991-07-24 | 1996-02-26 | Biochemie Gmbh | Pharmazeutische pleuromutilin-zubereitung |
GB9201751D0 (en) | 1992-01-28 | 1992-03-11 | Smithkline Beecham Plc | Compounds |
AT397654B (de) | 1992-05-04 | 1994-06-27 | Biochemie Gmbh | Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung |
EP0799202A1 (de) | 1994-12-23 | 1997-10-08 | Dr. Karl Thomae GmbH | Piperazinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
DE69629721T2 (de) * | 1996-01-03 | 2004-06-09 | Smithkline Beecham P.L.C., Brentford | Carnamoyloxy derivate von mutilin und deren verwendung als antibakterielles mittels |
HUP0001741A3 (en) | 1996-08-02 | 2000-11-28 | Smithkline Beecham Plc | Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use |
NZ334913A (en) | 1996-10-01 | 2001-03-30 | Smithkline Beecham Plc | Use of mupirocin (pseudomonic acid) for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms effective as a sprayable topical agent |
UY25225A1 (es) * | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
DE602004024417D1 (de) | 2003-09-03 | 2010-01-14 | Glaxo Group Ltd | Neues verfahren zur herstellung von pleuromutilinderivaten |
GB0504314D0 (en) | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
-
1996
- 1996-05-07 UY UY25225A patent/UY25225A1/es not_active IP Right Cessation
-
1998
- 1998-10-27 DK DK98950202T patent/DK1028961T5/da active
- 1998-10-27 CA CA002307551A patent/CA2307551C/en not_active Expired - Lifetime
- 1998-10-27 MY MYPI98004896A patent/MY130665A/en unknown
- 1998-10-27 TR TR2000/01203T patent/TR200001203T2/tr unknown
- 1998-10-27 EP EP04076485A patent/EP1452534A1/en not_active Withdrawn
- 1998-10-27 EP EP08152170A patent/EP1930330B1/en not_active Expired - Lifetime
- 1998-10-27 ZA ZA9809767A patent/ZA989767B/xx unknown
- 1998-10-27 AU AU96361/98A patent/AU742167C/en not_active Expired
- 1998-10-27 DE DE69826704T patent/DE69826704T3/de not_active Expired - Lifetime
- 1998-10-27 CN CNB988127318A patent/CN1205211C/zh not_active Expired - Lifetime
- 1998-10-27 EP EP98950202A patent/EP1028961B3/en not_active Expired - Lifetime
- 1998-10-27 DK DK08152170.0T patent/DK1930330T3/da active
- 1998-10-27 AT AT08152170T patent/ATE525373T1/de active
- 1998-10-27 WO PCT/GB1998/003211 patent/WO1999021855A1/en active IP Right Grant
- 1998-10-27 US US13/102,156 patent/USRE43390E1/en not_active Expired - Lifetime
- 1998-10-27 JP JP2000517965A patent/JP4227729B2/ja not_active Expired - Lifetime
- 1998-10-27 PL PL375435A patent/PL197672B1/pl unknown
- 1998-10-27 HU HU0004040A patent/HU229792B1/hu active Protection Beyond IP Right Term
- 1998-10-27 PT PT98950202T patent/PT1028961E/pt unknown
- 1998-10-27 NZ NZ504203A patent/NZ504203A/xx not_active IP Right Cessation
- 1998-10-27 US US10/631,707 patent/USRE39128E1/en not_active Ceased
- 1998-10-27 ES ES08152170T patent/ES2371205T3/es not_active Expired - Lifetime
- 1998-10-27 KR KR10-2000-7004707A patent/KR100538721B1/ko not_active IP Right Cessation
- 1998-10-27 SI SI9830932T patent/SI1930330T1/sl unknown
- 1998-10-27 CZ CZ20001551A patent/CZ298543B6/cs not_active IP Right Cessation
- 1998-10-27 ES ES98950202T patent/ES2229538T7/es active Active
- 1998-10-27 SI SI9830709T patent/SI1028961T1/xx unknown
- 1998-10-27 AR ARP980105377A patent/AR015987A1/es active IP Right Grant
- 1998-10-27 IL IL13581198A patent/IL135811A0/xx active IP Right Grant
- 1998-10-27 DE DE122007000076C patent/DE122007000076I2/de active Active
- 1998-10-27 AT AT98950202T patent/ATE277925T1/de active
- 1998-10-27 BR BRPI9814747-1A patent/BR9814747B1/pt not_active IP Right Cessation
- 1998-10-27 US US09/530,446 patent/US6281226B1/en not_active Ceased
- 1998-10-27 PL PL340254A patent/PL191927B1/pl unknown
- 1998-10-27 PT PT08152170T patent/PT1930330E/pt unknown
- 1998-10-28 DZ DZ980244A patent/DZ2634A1/xx active
- 1998-10-29 EG EG132598A patent/EG24177A/xx active
- 1998-10-29 CO CO98063556A patent/CO5021129A1/es unknown
- 1998-10-29 PE PE1998001018A patent/PE123299A1/es not_active Application Discontinuation
- 1998-11-24 TW TW087119420A patent/TWI232861B/zh not_active IP Right Cessation
-
2000
- 2000-04-24 IL IL135811A patent/IL135811A/en not_active IP Right Cessation
- 2000-04-27 NO NO20002173A patent/NO327392B1/no not_active IP Right Cessation
-
2001
- 2001-02-05 HK HK01100820A patent/HK1031376A1/xx not_active IP Right Cessation
-
2007
- 2007-10-24 LU LU91372C patent/LU91372I2/fr unknown
- 2007-11-06 NL NL300304C patent/NL300304I2/nl unknown
- 2007-11-09 FR FR07C0057C patent/FR07C0057I2/fr active Active
- 2007-11-12 CY CY200700028C patent/CY2007028I1/el unknown
-
2008
- 2008-08-25 JP JP2008215667A patent/JP2009040789A/ja active Pending
-
2009
- 2009-04-01 NO NO20091344A patent/NO20091344L/no not_active Application Discontinuation
- 2009-09-25 NO NO2009023C patent/NO2009023I2/no unknown
-
2011
- 2011-10-31 CY CY20111101037T patent/CY1112062T1/el unknown
-
2014
- 2014-12-18 HU HUS1400060C patent/HUS1400060I1/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24412A (en) | Novel compounds | |
EG24177A (en) | Novel compounds | |
GB9701684D0 (en) | Novel compounds | |
GB9706255D0 (en) | Novel compounds | |
GB9707830D0 (en) | Novel compounds | |
GB9703492D0 (en) | Novel compounds | |
GB9705619D0 (en) | Novel compounds | |
GB9706525D0 (en) | Novel compounds | |
GB9700689D0 (en) | Novel compounds | |
GB9700694D0 (en) | Novel compounds | |
GB9700901D0 (en) | Novel compounds | |
GB9700902D0 (en) | Novel compounds | |
GB9701597D0 (en) | Novel compounds | |
GB9700687D0 (en) | Novel compounds | |
GB9703011D0 (en) | Novel compounds | |
GB9703333D0 (en) | Novel compounds | |
GB9703334D0 (en) | Novel compounds | |
GB9703402D0 (en) | Novel compounds | |
GB9703491D0 (en) | Novel compounds | |
GB9700591D0 (en) | Novel compounds | |
GB9703493D0 (en) | Novel compounds | |
GB9704461D0 (en) | Novel compounds | |
GB9704462D0 (en) | Novel compounds | |
GB9705385D0 (en) | Novel compounds | |
GB9700590D0 (en) | Novel compounds |